New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
07:12 EDTEVGN, BAYRYEvogene announces amendment to Bayer wheat agreement
Evogene (EVGN) announced an amendment to the remaining work plan under its collaboration with Bayer CropScience LP (BAYRY) for improved wheat. Pursuant to the amended work plan, Evogene will shift from discovery of additional genes and SNP’s to discovery of novel genomic promoters. Under the amended agreement, Evogene will continue in close teamwork with Bayer to utilize its ATHLETE discovery platform but will shift the focus from the discovery of additional genes and SNP's to identifying novel genomic promoters.
News For EVGN;BAYRY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 4, 2015
11:04 EDTBAYRYIsis Pharmaceuticals partnership deal generally expected, says Piper Jaffray
Piper Jaffray noted that Isis Pharmaceuticals (ISIS) had been indicating a high level of interest in its FXIrx anti-clotting antisense program ahead of announcing its deal with Bayer (BAYRY) and the firm believes the announcement of a partnership pact was generally expected. The firm said it already included "meaningful" economics from the FXI program in its valuation for Isis and maintains a Neutral rating on the stock, which is up 4.6% to $60.92 in morning trading.
09:03 EDTBAYRYIsis Pharmaceuticals enters into license agreement with Bayer HealthCare
Subscribe for More Information
07:26 EDTBAYRYWorldwide Business Research to hold a conference
BioNetwork East 2015 Partnering Conference is being held in Miami on May 4-6.
07:12 EDTBAYRYAmerican Congress of Obstetrics and Gynecology
2015 ACOG Annual Clinical & Scientific Meeting is being held in San Francisco on May 2-6.
April 30, 2015
09:36 EDTBAYRYBayer says Xarelto not losing market share to Eliquis, Reuters reports
Bayer (BAYRY) says Xarelto is not losing its U.S. market share to Bristol-Myers' (BMY) Eliquis, reports Reuters. In a conference call, Bayer said that Eliquis was taking business from warfarin and other drugs, but not from Xarelto. Reference Link
05:27 EDTBAYRYBayer sees FY15 sales EUR 48B-EUR 49B
Subscribe for More Information
05:23 EDTBAYRYBayer reports Q1 Healthcare sales up 25.6% to EUR 5.74B
Subscribe for More Information
05:22 EDTBAYRYBayer reports Q1 net income EUR 1.30B vs. EUR 1.42B
Subscribe for More Information
April 22, 2015
12:49 EDTBAYRYEU proposes new law that allows states to ban biotech crops, WSJ reports
Subscribe for More Information
07:07 EDTBAYRYEuropean Association for the Study of the Liver to hold annual meeting
50th Annual Meeting of EASL will be held in Vienna, Austria on April 22-26.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use